OBJECTIVE: Embryo-derived PreImplantation Factor (PIF) is essential for pregnancy immune modulation and synthetic PIF (sPIF), reverses neuroinflammation, and prevents diabetes mellitus through its immune modulatory properties. Herein, we explore sPIF's systemic effects on peripheral blood mononuclear cells (PBMCs). STUDY DESIGN: sPIF's effects on PBMCs and subset populations from nonpregnant patients (n = 7) and male patients were evaluated by the assessment of binding characteristics, mixed lymphocyte reaction, proliferation, cytokine secretion, and associated gene expression. Data analysis was by analysis of variance (P < .05). RESULTS: Fluorescein isothiocyanate-sPIF bound all myelomonocytic cells; binding was 30-fold up-regulated in mitogen-activated T and B cells (P < .05). sPIF decreased mixed lymphocyte reaction by 70% and blocked anti-CD3 antibody stimulated-PBMC proliferation by approximately 80% (P < .05). In naïve PBMCs, sPIF reduced interleukin (IL)-10 and -2; in activated PBMCs, sPIF increased IL-4, -5, -10, and -2, tumor necrosis factor-α, interferon-γ, and granulocyte-macrophage colony-stimulating factor (P < .05). CONCLUSION: Physiologic concentrations of PIF exert potent systemic antiinflammatory effects on nonpregnant activated immune cells.
OBJECTIVE: Embryo-derived PreImplantation Factor (PIF) is essential for pregnancy immune modulation and synthetic PIF (sPIF), reverses neuroinflammation, and prevents diabetes mellitus through its immune modulatory properties. Herein, we explore sPIF's systemic effects on peripheral blood mononuclear cells (PBMCs). STUDY DESIGN: sPIF's effects on PBMCs and subset populations from nonpregnant patients (n = 7) and male patients were evaluated by the assessment of binding characteristics, mixed lymphocyte reaction, proliferation, cytokine secretion, and associated gene expression. Data analysis was by analysis of variance (P < .05). RESULTS:Fluorescein isothiocyanate-sPIF bound all myelomonocytic cells; binding was 30-fold up-regulated in mitogen-activated T and B cells (P < .05). sPIF decreased mixed lymphocyte reaction by 70% and blocked anti-CD3 antibody stimulated-PBMC proliferation by approximately 80% (P < .05). In naïve PBMCs, sPIF reduced interleukin (IL)-10 and -2; in activated PBMCs, sPIF increased IL-4, -5, -10, and -2, tumor necrosis factor-α, interferon-γ, and granulocyte-macrophage colony-stimulating factor (P < .05). CONCLUSION: Physiologic concentrations of PIF exert potent systemic antiinflammatory effects on nonpregnant activated immune cells.
Authors: M Mueller; A Schoeberlein; J Zhou; M Joerger-Messerli; B Oppliger; U Reinhart; A Bordey; D Surbek; E R Barnea; Y Huang; M Paidas Journal: Cell Death Differ Date: 2015-05-15 Impact factor: 15.828
Authors: Martin Mueller; Jichun Zhou; Lihua Yang; Yuan Gao; Fuju Wu; Andreina Schoeberlein; Daniel Surbek; Eytan R Barnea; Michael Paidas; Yingqun Huang Journal: Proc Natl Acad Sci U S A Date: 2014-09-09 Impact factor: 11.205
Authors: Eytan R Barnea; David M Lubman; Yan-Hui Liu; Victor Absalon-Medina; Soren Hayrabedyan; Krassimira Todorova; Robert O Gilbert; Joy Guingab; Timothy J Barder Journal: PLoS One Date: 2014-07-01 Impact factor: 3.240
Authors: Nicoletta Di Simone; Fiorella Di Nicuolo; Riccardo Marana; Roberta Castellani; Francesco Ria; Manuela Veglia; Giovanni Scambia; Daniel Surbek; Eytan Barnea; Martin Mueller Journal: PLoS One Date: 2017-07-12 Impact factor: 3.240
Authors: Giuseppe Migliara; Martin Mueller; Alessia Piermattei; Chaya Brodie; Michael J Paidas; Eytan R Barnea; Francesco Ria Journal: Oncotarget Date: 2017-03-28
Authors: Marco Sbracia; Brett McKinnon; Fabio Scarpellini; Daniela Marconi; Gabriele Rossi; Cedric Simmilion; Michael D Mueller; Eytan R Barnea; Martin Mueller Journal: PLoS One Date: 2017-09-13 Impact factor: 3.240